Moreau, Philippe <br/><br/>
Pharmacokinetic, pharmacodynamic and covariate analysis of subcutaneous versus intravenous administration of bortezomib in patients with relapsed multiple myeloma.  [electronic resource] 

 -  Clinical pharmacokinetics  Dec 2012 
 - 823-9 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase I; Clinical Trial, Phase III; Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1179-1926 
<br/><br/><label>Standard No.: </label>10.1007/s40262-012-0010-0  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Administration, Intravenous<br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Antineoplastic Agents--administration & dosage<br/>Area Under Curve<br/>Boronic Acids--administration & dosage<br/>Bortezomib<br/>Humans<br/>Injections, Subcutaneous<br/>Middle Aged<br/>Multiple Myeloma--blood<br/>Proteasome Endopeptidase Complex--blood<br/>Pyrazines--administration & dosage<br/>Recurrence